C.C. Paarthipan (#3311)
- $ 1 B
- pharmaceuticals
- India
- M
- 72 Years
Mira Murati’s deposition pulled back the curtain on Sam Altman’s ouster
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
TOUCHMARK BANCSHARES, INC. REPORTS FIRST QUARTER RESULTS
Kevin Hassett Says It’s Good Sign Americans Using Credit Cards More As Iran War Blows Up Their Budgets
Iran war threatens jet fuel shortage that could disrupt summer travel in Asia and Europe
'This Is Yours!': Whoopi Goldberg Turns Marco Rubio's Words For Iran Against Him
Catalyst Professorship fosters collaboration with the private sector
Anthropic CEO Predicts SaaS Pivot as AI Coding Surges
PRISM MarketView Launches Emerging Semiconductors Index
About Me
C.C.Paarthipan founded and chairs Chennai pharma company Caplin Point Laboratories. The company sells generics across Latin America, Africa, the U.S. and the Caribbean. His older son Ashok heads the Latin American business while younger son Vivek is the chief operating officer. He listed the company in 1994. It was oversubscribed 117 times. He started as a medical rep in the 1980s and then founded Caplin in 1990 for making ointments and creams
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped C.C. Paarthipan’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking C.C. Paarthipan’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $1.1B
(May 7, 2026)
© Iconic Billionaires